NK cell characteristics in neurodegenerative diseases
| Disease . | Circulating NK cells . | CSF NK cells . | CNS parenchyma NK cells . | Predominant phenotype . | Activation/functional status . | Protective mechanisms . | Detrimental effects . |
|---|---|---|---|---|---|---|---|
| MS | Altered number | ↑ | ↑ Accumulate in active lesions near T cells | CD56bright | Variable cytolytic activity during relapses | Kills autoreactive CD4+ T cells; secretes acetylcholine and immunosuppressive cytokines; NKG2C+ and NKG2D+ subsets eliminate EBV-induced autoreactive clones | NKp46+/NK1.1+ ILCs promote brain barrier permeabilization and T cell CNS entry; autoreactive B cells evade killing via HLA-E upregulation |
| AD | Unchanged | ↑ | Not well defined | CD56bright (predominant in CNS) | Proinflammatory in CSF during MCI; variable blood; NK cytotoxicity (increased to impaired) | Direct uptake/degradation of Aβ; restores microglial phagocytosis; reduces neuroinflammation; meningeal NK-derived IFN-γ promotes memory formation | Chronic activation leads to overproduction of IFN-γ and TNF-α (inversely correlates with cognition); depletion in mouse models reduces neuroinflammation but impairs early protective effects |
| PD | ↑ | ↑ | ↑ Infiltrate substantia nigra; colocalize with α-syn aggregates and dopaminergic neurons | CD56dim (blood) | Elevated activation markers; correlates with severity/progression | Clear α-syn aggregates; likely eliminates autoreactive T cells | α-syn clearance reduces NK cytolytic capacity and IFN-γ secretion, potential dysfunction with chronic activation |
| Disease . | Circulating NK cells . | CSF NK cells . | CNS parenchyma NK cells . | Predominant phenotype . | Activation/functional status . | Protective mechanisms . | Detrimental effects . |
|---|---|---|---|---|---|---|---|
| MS | Altered number | ↑ | ↑ Accumulate in active lesions near T cells | CD56bright | Variable cytolytic activity during relapses | Kills autoreactive CD4+ T cells; secretes acetylcholine and immunosuppressive cytokines; NKG2C+ and NKG2D+ subsets eliminate EBV-induced autoreactive clones | NKp46+/NK1.1+ ILCs promote brain barrier permeabilization and T cell CNS entry; autoreactive B cells evade killing via HLA-E upregulation |
| AD | Unchanged | ↑ | Not well defined | CD56bright (predominant in CNS) | Proinflammatory in CSF during MCI; variable blood; NK cytotoxicity (increased to impaired) | Direct uptake/degradation of Aβ; restores microglial phagocytosis; reduces neuroinflammation; meningeal NK-derived IFN-γ promotes memory formation | Chronic activation leads to overproduction of IFN-γ and TNF-α (inversely correlates with cognition); depletion in mouse models reduces neuroinflammation but impairs early protective effects |
| PD | ↑ | ↑ | ↑ Infiltrate substantia nigra; colocalize with α-syn aggregates and dopaminergic neurons | CD56dim (blood) | Elevated activation markers; correlates with severity/progression | Clear α-syn aggregates; likely eliminates autoreactive T cells | α-syn clearance reduces NK cytolytic capacity and IFN-γ secretion, potential dysfunction with chronic activation |